Nuzyra

Chemical Nameomadacycline
Dosage FormInjection (intravenous; 100 mg) Tablet (oral; 300 mg)
Drug ClassTetracyclines
SystemRespiratory, Skin
CompanyParatek Pharmaceuticals, Inc.
Approval Year2018

Indication

  • To treat community-acquired bacterial pneumonia in adults.
  • To treat skin structure infections in adults.
  • To treat acute bacterial skin infections in adults.
Last updated on 10/13/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Nuzyra (Omadacycline) Prescribing Information 2018Paratek Pharmaceuticals, Inc., Boston, MA